| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,762,894 |
|
|
|
Indirect Value
|
$270,797 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,033,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-21 |
4 |
OE |
$381.92 |
$152,768 |
D/D |
400 |
29,056 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-31 |
4 |
OE |
$378.98 |
$151,592 |
D/D |
400 |
23,856 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-02-02 |
4 |
OE |
$378.98 |
$151,592 |
D/D |
400 |
23,974 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-02 |
4 |
D |
$888.34 |
$373,991 |
D/D |
(421) |
22,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-31 |
4 |
AS |
$487.88 |
$210,693 |
D/D |
(427) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-23 |
4 |
AS |
$474.14 |
$222,981 |
D/D |
(468) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-06 |
4 |
AS |
$496.51 |
$235,873 |
D/D |
(474) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-11-01 |
4 |
AS |
$750.00 |
$365,386 |
D/D |
(482) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-09 |
4 |
D |
$753.28 |
$370,614 |
D/D |
(492) |
28,991 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-12 |
4 |
OE |
$272.70 |
$136,350 |
D/D |
500 |
25,473 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-04 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
22,948 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-17 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
23,338 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-24 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
23,808 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-06-23 |
4 |
AS |
$624.65 |
$323,212 |
D/D |
(512) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-08 |
4 |
AS |
$469.91 |
$248,372 |
D/D |
(526) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-10 |
4 |
AS |
$611.00 |
$328,593 |
D/D |
(537) |
25,903 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-27 |
4 |
D |
$872.21 |
$472,738 |
D/D |
(542) |
21,569 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-12 |
4 |
D |
$928.18 |
$527,206 |
D/D |
(568) |
22,838 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-14 |
4 |
AS |
$640.50 |
$370,850 |
D/D |
(579) |
23,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-01 |
4 |
AS |
$478.97 |
$292,811 |
D/D |
(600) |
24,373 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-02 |
4 |
AS |
$756.50 |
$461,564 |
D/D |
(610) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-28 |
4 |
D |
$884.88 |
$541,547 |
D/D |
(612) |
21,807 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-02 |
4 |
OE |
$378.98 |
$246,337 |
D/D |
650 |
22,457 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-11-17 |
4 |
AS |
$645.08 |
$439,299 |
D/D |
(681) |
25,986 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-03 |
4 |
AS |
$489.50 |
$337,592 |
D/D |
(683) |
24,373 |
0 |
% |
|
158 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
